285 related articles for article (PubMed ID: 35537918)
1. Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose.
Weiner SG; Carroll AD; Brisbon NM; Rodriguez CP; Covahey C; Stringfellow EJ; DiGennaro C; Jalali MS; Wakeman SE
J Subst Abuse Treat; 2022 Aug; 139():108785. PubMed ID: 35537918
[TBL] [Abstract][Full Text] [Related]
2. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
3. Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults.
Lin LA; Brummett CM; Waljee JF; Englesbe MJ; Gunaseelan V; Bohnert ASB
J Gen Intern Med; 2020 Feb; 35(2):420-427. PubMed ID: 31820218
[TBL] [Abstract][Full Text] [Related]
4. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
[TBL] [Abstract][Full Text] [Related]
5. Characterizing and combating the opioid epidemic in the Los Angeles County jail system.
Tran NT; Muradian IK; Qureshi N; Singh J; Henderson SO
J Subst Use Addict Treat; 2023 Apr; 147():208984. PubMed ID: 36841073
[TBL] [Abstract][Full Text] [Related]
6. Racial inequities in U.S. naloxone prescriptions.
Madden EF; Qeadan F
Subst Abus; 2020; 41(2):232-244. PubMed ID: 31718487
[No Abstract] [Full Text] [Related]
7. Implementation and maintenance of an emergency department naloxone distribution and peer recovery specialist program.
Jacka BP; Ziobrowski HN; Lawrence A; Baird J; Wentz AE; Marshall BDL; Wightman RS; Mello MJ; Beaudoin FL; Samuels EA
Acad Emerg Med; 2022 Mar; 29(3):294-307. PubMed ID: 34738277
[TBL] [Abstract][Full Text] [Related]
8. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
9. Rhode Island's Opioid Overdose Hospital Standards and Emergency Department Naloxone Distribution, Behavioral Counseling, and Referral to Treatment.
Samuels EA; Wentz A; McCormick M; McDonald JV; Marshall BDL; Friedman C; Koziol J; Alexander-Scott NE
Ann Emerg Med; 2021 Jul; 78(1):68-79. PubMed ID: 33865617
[TBL] [Abstract][Full Text] [Related]
10. Disparities in Emergency Department Naloxone and Buprenorphine Initiation.
Papp J; Emerman C
West J Emerg Med; 2023 Jun; 24(4):710-716. PubMed ID: 37527392
[TBL] [Abstract][Full Text] [Related]
11. Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose.
Follman S; Arora VM; Lyttle C; Moore PQ; Pho MT
JAMA Netw Open; 2019 May; 2(5):e193209. PubMed ID: 31050777
[TBL] [Abstract][Full Text] [Related]
12. Associations between naloxone prescribing and opioid overdose among patients with acute and chronic pain conditions.
Qeadan F; Madden EF
Addiction; 2022 Feb; 117(2):457-471. PubMed ID: 34286895
[TBL] [Abstract][Full Text] [Related]
13. Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose.
Essien UR; Sileanu FE; Zhao X; Liebschutz JM; Thorpe CT; Good CB; Mor MK; Radomski TR; Hausmann LRM; Fine MJ; Gellad WF
J Gen Intern Med; 2020 May; 35(5):1537-1544. PubMed ID: 31965528
[TBL] [Abstract][Full Text] [Related]
14. Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island.
Nolen S; Zang X; Chatterjee A; Behrends CN; Green TC; Kumar A; Linas BP; Morgan JR; Murphy SM; Walley AY; Yan S; Schackman BR; Marshall BDL
Addiction; 2022 May; 117(5):1372-1381. PubMed ID: 34825427
[TBL] [Abstract][Full Text] [Related]
15. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
[TBL] [Abstract][Full Text] [Related]
16. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
[TBL] [Abstract][Full Text] [Related]
17. Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City.
Khan MR; Hoff L; Elliott L; Scheidell JD; Pamplin JR; Townsend TN; Irvine NM; Bennett AS
Harm Reduct J; 2023 Feb; 20(1):24. PubMed ID: 36841763
[TBL] [Abstract][Full Text] [Related]
18. Race, ethnicity, and emergency department post-overdose care.
Reddy NG; Jacka B; Ziobrowski HN; Wilson T; Lawrence A; Beaudoin FL; Samuels EA
J Subst Abuse Treat; 2021 Dec; 131():108588. PubMed ID: 34384652
[TBL] [Abstract][Full Text] [Related]
19. Modifying and Evaluating the Opioid Overdose Knowledge Scale for Prescription Opioids: A Pilot Study of the Rx-OOKS.
Shoup JA; Mueller SR; Binswanger IA; Williams AV; Strang J; Glanz JM
Pain Med; 2020 Oct; 21(10):2244-2252. PubMed ID: 32827044
[TBL] [Abstract][Full Text] [Related]
20. Disparities in naloxone prescriptions in a University Hospital during the COVID-19 pandemic.
Chieh K; Patel I; Walter L; Li L
Harm Reduct J; 2022 Jul; 19(1):84. PubMed ID: 35883136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
